Back to
UBS Group AG
GLMD8 quarters
Position history for
UBS Group AG's holdings in GALMED PHARMACEUTICALS LTD
UBS Group AG holds 3 shares of GLMD (GALMED PHARMACEUTICALS LTD), worth $2 as of 2026-Q2. The position was decreased (-99.9% shares).
Current Value
$2
Current Shares
3
Total Value Change
-$36,130
Total Shares Change
-5,264
Quarter-by-Quarter History
Other major holders of GLMD: TWO SIGMA INVESTMENTS, LP, Schonfeld Strategic Advisors LLC, CITADEL ADVISORS LLC, MORGAN STANLEY